Immuneering Corp (IMRX)
1.54
-0.03
(-1.91%)
USD |
NASDAQ |
May 16, 16:00
1.54
0.00 (0.00%)
After-Hours: 20:00
Immuneering Accounts Payable (Quarterly): 2.271M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.271M |
| December 31, 2023 | 2.112M |
| September 30, 2023 | 1.941M |
| June 30, 2023 | 2.693M |
| March 31, 2023 | 2.724M |
| December 31, 2022 | 3.155M |
| September 30, 2022 | 2.338M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.240M |
| March 31, 2022 | 1.642M |
| December 31, 2021 | 1.394M |
| September 30, 2021 | 1.795M |
| June 30, 2021 | 1.432M |
| March 31, 2021 | 1.369M |
| December 31, 2020 | 1.480M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.240M
Minimum
Jun 2022
3.155M
Maximum
Dec 2022
1.970M
Average
1.868M
Median
Accounts Payable (Quarterly) Benchmarks
| Geron Corp | 9.992M |
| SELLAS Life Sciences Group Inc | 7.407M |
| Elicio Therapeutics Inc | 4.369M |
| Vistagen Therapeutics Inc | 1.737M |
| ADMA Biologics Inc | 17.19M |